Clinical Trials Logo

Clinical Trial Summary

The Pivotal Study of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve). This study follows the EFS and is now to determine the safety and efficacy of the Cormatrix Cor TRICUSPID Valve for any patients requiring surgical replacement of the tricuspid valve.


Clinical Trial Description

CorMatrix Cardiovascular, Inc. has developed a device for heart valve replacement, the CorMatrix® Cor ECM® Tricuspid Valve, which can be implanted to replace dysfunctional tricuspid heart valves. This Pivotal Study is being performed to verify the ability to successfully implant the Tricuspid Valve, the clinical safety of the device, and whether the device performs its intended use. The study is a multi-center, prospective, single-arm, Pivotal Study of subjects receiving the Cor TRICUSPID ECM Valve or Cor PEDIATRIC Tricuspid ECM Valve. The study will be conducted at up to 15 sites. Up to 60 subjects will undergo tricuspid valve replacement (TVR) with the CorMatrix ECM Valve for the surgical management of tricuspid valve disease. The cohort will include up to 60 adult and 18 pediatric patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02397668
Study type Interventional
Source CorMatrix Cardiovascular, Inc.
Contact Robert G Matheny, MD
Phone 404-276-7777
Email rmatheny@cormatrix.com
Status Recruiting
Phase N/A
Start date August 1, 2022
Completion date December 15, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06001489 - The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy N/A
Active, not recruiting NCT04950192 - Philips Intracardiac Echocardiography (ICE) Clinical Registry
Terminated NCT04665583 - Prehab Prior to Undergoing Tricuspid Intervention
Recruiting NCT03546231 - Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation
Recruiting NCT05797519 - Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation N/A
Not yet recruiting NCT06137807 - TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV) N/A
Recruiting NCT04231461 - Quality of Life After Cardiac Surgery
Completed NCT03239262 - Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation N/A
Not yet recruiting NCT06235385 - European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study
Recruiting NCT03859102 - Enhanced Recovery After Cardiac Surgery N/A
Recruiting NCT04097145 - Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial N/A
Recruiting NCT05742906 - CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study N/A
Recruiting NCT05961150 - PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry
Recruiting NCT04482062 - TRISCEND II Pivotal Trial N/A
Active, not recruiting NCT05064514 - Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease N/A
Recruiting NCT05913908 - EFS of the DUO System for Tricuspid Regurgitation (TANDEM II) N/A
Recruiting NCT05848284 - Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US) N/A